HealthIT Answers November 19, 2021
HHS/ONC/CMS Communications

Will Consider Other Coverage Pathways to Enhance Access to Innovative Medical Devices

The Agency will explore evidence-based approaches that protect people with Medicare

The Centers for Medicare and Medicare Services (CMS) (@CMSGov) is rescinding the Medicare Coverage of Innovative Technology and Definition of “Reasonable and Necessary” (MCIT/R&N) final rule because of concerns that the provisions in the final rule may not have been sufficient to protect Medicare patients. By rescinding this rule, CMS can take action that will better address those safety concerns in the future.

“Although we continue to be in favor of enhancing access to new technologies, we are mindful that they may have unknown or unexpected risks and must first ensure such technologies improve health outcomes for...

Today's Sponsors

Patient Bond
Institute for Healthcare Improvement

Today's Sponsors

Oliver Wyman
Patient Bond

Today's Sponsor

Patient Bond

Topics: CMS, Govt Agencies, Insurance, Medical Devices, Medicare
Inside the Rollout of CMS’ Value-Based Opioid Treatment Pilot Program
CMS moves boost value-based care in ASCs
CMS Proposes Changes to Part D Regulations: Pharmacy Price Concessions
Medical societies urge CMS to improve provider engagement in developing Medicare local coverage policies
CMS Wants States to Lock in Telehealth Changes for Behavioral Health, Other Areas